Slideshow

Endo News Roundup: Diabetes Prevention and Remission

Author(s):

Three new diabetes-related studies include these highlights: for those at risk of developing diabetes, long-term use of metformin does not worsen cognitive performance; a score from a validated nomogram predicts diabetes remission with either sleeve gastrectomy or gastric bypass surgery; and another scoring system predicts type 2 diabetes mellitus (DM) remission at 1 year following bariatric surgery.References Long-term Metformin Does Not Affect Cognitive Function Luchsinger JA, et al. Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study. Diabetes Care 2017 May; dc162376. https://doi.org/10.2337/dc16-2376Score Predicts Best Surgery for Diabetes Remission Aminian A, et al. Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity. American Surgical Association 2017 Annual Meeting. April 22, 2017; Philadelphia, Pennsylvania. Scientific Session V, Presentation 27.Validation of Bariatric Surgery Score for Type 2 DM Khowaja A, et. al. Predictability Of Diabetes Mellitus Type 2 Remission And Changes In Metabolic Profile After Bariatric Surgery Using Diarem Scoring System. American Association of Clinical Endocrinologists (AACE) 2017 Annual Scientific & Clinical Congress. May 6, 2017; Austin, Texas. Abstract 1158.

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.